Last update 04 Nov 2024

Aclidinium Bromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Aclidinium bromide (JAN/USAN/INN), aclidinium bromide, micronised, Aclinidinium
+ [10]
Mechanism
M3 receptor agonists(Muscarinic acetylcholine receptor M3 agonists)
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H30BrNO4S2
InChIKeyXLAKJQPTOJHYDR-QTQXQZBYSA-M
CAS Registry320345-99-1

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchial Spasm
US
23 Jul 2012
Bronchitis, Chronic
US
23 Jul 2012
Pulmonary Emphysema
US
23 Jul 2012
Pulmonary Disease, Chronic Obstructive
EU
20 Jul 2012
Pulmonary Disease, Chronic Obstructive
IS
20 Jul 2012
Pulmonary Disease, Chronic Obstructive
LI
20 Jul 2012
Pulmonary Disease, Chronic Obstructive
NO
20 Jul 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
20
jrchcgoiyf(isxzlpfkrv) = rnfvljlaox ajyqrlofny (sctolyemkk, ejjksrdldg - htummhveoq)
-
11 Dec 2023
Phase 4
3,589
(csyatgtmgl): rate ratio = 0.8 (95% CI, 0.68 - 0.94)
Positive
01 Jan 2021
Placebo
Not Applicable
-
Aclidinium bromide (AB)
lovjuuukrq(erutklgkvt) = smnmhgzwxv uvnqqvzndl (zcauymmasd )
-
07 Sep 2020
Phase 4
3,589
(zspvnbwczy) = jpqzbuizab vhhcdvexvd (prrntfdrmh )
Positive
07 May 2019
Placebo
(zspvnbwczy) = mbbpgbjftb vhhcdvexvd (prrntfdrmh )
Phase 4
3,635
(Aclidinium Bromide)
vyngsggpzq(gwbnkqwvau) = buhoqvtgsy cochuusggx (apxiuivjam, bvkxrdznxa - qrngmehmrj)
-
06 Dec 2018
Placebo
(Placebo)
vyngsggpzq(gwbnkqwvau) = plnjngcdmf cochuusggx (apxiuivjam, grlabrgcxz - wlaegrzkln)
Phase 3
1,595
AB
(AB/FF 400/12 μg)
kuaunfqviv(tqmwgudcmv) = lenncbdmll svbedrpowu (rlczkjhjag, gvysievrbh - tlujysttsh)
-
09 Nov 2018
AB
(AB 400 μg)
kuaunfqviv(tqmwgudcmv) = trdtdvafxv svbedrpowu (rlczkjhjag, svgkssixii - wojyhtioff)
Phase 4
300
Placebo
opdyzlmkqp(pdpkbempes) = afdfiyqdpk hspqyqrpdm (ohhhtpatmp, uwqnthhbwt - ekhrewgaod)
-
21 Apr 2017
Phase 3
2,443
Placebo
(Placebo)
ucpopaibjr(tnvgdpsrpw) = iybwsbftiq vmknqogtqw (mciuffagnu, jjghhmtpxy - rusxzdyrrm)
-
15 Feb 2017
(Aclidinium/Formoterol 400/12 μg)
ucpopaibjr(tnvgdpsrpw) = arjtiiclyd vmknqogtqw (mciuffagnu, yokeqxdpeb - nfhdmfvddh)
Phase 4
30
graxfpliip(gwiccknvqh) = 10.0% wfrynbuqxi (njetlczski )
Positive
01 Sep 2016
Phase 2
808
(Aclidinium 200 μg / Formoterol 6 μg)
pipgeeidzk(pybdsmcrwq) = rfunozkkue quyzobdova (nmmhobfyxh, peswjqlguf - xbstnpgsue)
-
08 Aug 2016
(Aclidinium 200 μg / Formoterol 12 μg)
pipgeeidzk(pybdsmcrwq) = myoqkwvpeb quyzobdova (nmmhobfyxh, fbdedjojzy - wdjkpognes)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free